Clinical Trial Update: Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients" [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating the therapeutic effect of atorvastatin in HER2-negative breast cancer across Phase 2 and Phase 3 stages; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Not specified
• atorvastatin (atorvastatin)

Snippet

Sponsor: Beni-Suef University | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: UNKNOWN